Mohamed Badr

Novel 4-(piperazin-1-yl)quinolin-2(1H)-one bearing thiazoles with antiproliferative activity through VEGFR-2-TK inhibition

Abdelfattah Hassan, Mohamed Badr, Heba A. Hassan et al. · Bioorganic & Medicinal Chemistry · 2021 · 38 citations · Full text

Medicinal Chemistry, Bearing Thiazoles, Medicine +4

Chemical constituents from <i>Carica papaya</i> Linn. leaves as potential cytotoxic, EGFR^wt and aromatase (CYP19A) inhibitors; a study supported by molecular docking

Ashraf Hamed, Mohamed E. Abouelela, Ahmed E. El Zowalaty et al. · RSC Advances · 2022 · 35 citations · Full text

Thiazolidine-2,4-dione-linked ciprofloxacin derivatives with broad-spectrum antibacterial, MRSA and topoisomerase inhibitory activities

Hossameldin A. Aziz, Ahmed M. M. El‐Saghier, Mohamed Badr et al. · Molecular Diversity · 2021 · 34 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Antibiotics +12

Utilization of cyanopyridine in design and synthesis of first-in-class anticancer dual acting PIM-1 kinase/HDAC inhibitors

Amr K. A. Bass, El-Shimaa M. Nageeb, Mona S. El‐Zoghbi et al. · Bioorganic Chemistry · 2021 · 31 citations

Medicinal Chemistry, First-in-class Anticancer, Medicine +9

Design and biological evaluation of 3-substituted quinazoline-2,4(1 <i>H</i> ,3 <i>H</i> )-dione derivatives as dual c-Met/VEGFR-2-TK inhibitors

Abdelfattah Hassan, Fawzy A. F. Mubarak, Ihsan A. Shehadi et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2023 · 28 citations · Full text